Intra-Cellular Therapies $14.6 billion acquisition by Johnson & Johnson
We are advising Intra-Cellular Therapies on the transaction
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
The Baldwin Group $935 million credit facilities financing
We advised the borrower on the refinancing and amendment
CRH $3 billion guaranteed notes offering
The investment-grade notes are due 2030, 2035 and 2055
iHeart comprehensive out-of-court debt restructuring
We advised an ad hoc group of noteholders and term loan lenders on the transaction
Royalty Pharma $1.1 billion acquisition of its external manager and $3 billion share repurchase
We are advising Royalty Pharma on the transaction
BrainAurora Medical Technology HK$583 million IPO
We advised BrainAurora on its IPO and HKEX listing
Veritas Technologies comprehensive debt recapitalization transaction
We advised an ad hoc group of term lenders and noteholders on the transaction
General Motors Financial $2.5 billion senior notes offering
The investment-grade notes are due 2030 and 2035
Big Lots sale of substantially all of its assets to Gordon Brothers Retail Partners
We advised Big Lots on the sale
GrafTech International capital raise and exchange transaction
We advised an ad hoc group of noteholders and the first-lien term loan administrative and collateral agent on the transaction